TCM Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Hold
0
– – – 30
2026
Q1
– Hold
0
– – – 26
2025
Q4
– Hold
0
– – – 22
2025
Q3
– Hold
0
– – – 20
2025
Q2
– Hold
0
– – – 26
2025
Q1
– Hold
0
– – – 22
2024
Q4
– Hold
0
– – – 32
2024
Q3
– Hold
0
– – – 27
2024
Q2
– Hold
0
– – – 23
2024
Q1
– Hold
0
– – – 24
2023
Q4
– Hold
0
– – – 27
2023
Q3
– Hold
0
– – – 33
2023
Q2
– Hold
0
– – – 41
2023
Q1
– Hold
0
– – – 41
2022
Q4
– Hold
0
– – – 36
2022
Q3
– Hold
0
– – – 29
2022
Q2
– Hold
0
– – – 28
2022
Q1
– Sell
-10,500
Closed -$1.11M – 28
2021
Q4
$1.08M Buy
+10,500
New +$1.22M 0.95% 37

Other funds holding MDT

TCM Advisors's MDT Position: Q2 2026 in Review

TCM Advisors held its Medtronic (MDT) position steady in Q2 2026 at 0 shares worth $901K. The position accounts for 0.07% of the portfolio, ranked #30.

TCM Advisors first reported a position in MDT in Q4 2021 and has held it in 1 quarter since. The position peaked at $1.08M in Q4 2021. 2,149 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • TCM Advisors held 0 shares of Medtronic worth $901K as of Q2 2026.
  • TCM Advisors left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.07% of TCM Advisors's portfolio in Q2 2026, its #30 holding.
  • TCM Advisors first reported a position in Medtronic in Q4 2021 and has held it in 1 quarter since.
  • TCM Advisors's Medtronic position peaked at $1.08M in Q4 2021.
  • 2,149 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TCM Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.